Efficiency and acceptability of two-stage therapy for recurrent bacterial vaginosis
- Авторлар: Uruimagova A.T.1, Prilepskaya V.N.1, Mezhevitinova E.A.1, Donnikov A.E.1, Abakarova P.R.1, Dovletkhanova E.R.1, Gusakov K.I.1, Odyvanova A.A.1
-
Мекемелер:
- Academician V.I. Kulakov National Medical Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
- Шығарылым: № 11 (2021)
- Беттер: 202-212
- Бөлім: Articles
- URL: https://journals.eco-vector.com/0300-9092/article/view/249477
- DOI: https://doi.org/10.18565/aig.2021.11.202-212
- ID: 249477
Дәйексөз келтіру
Аннотация
Негізгі сөздер
Толық мәтін
![Рұқсат жабық](https://journals.eco-vector.com/lib/pkp/templates/images/icons/text_lock.png)
Авторлар туралы
Ada Uruimagova
Academician V.I. Kulakov National Medical Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
Email: ada.uruimagova@yandex.ru
post-graduate student of the Department of Obstetrics, Gynecology, Perinatology and Reproductology
Vera Prilepskaya
Academician V.I. Kulakov National Medical Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
Email: vpnlepskaya@mail.ru
Dr. Med. Sci., Professor, Honored Scientist of the Russian Federation, Head of the Scientific Polyclinic Department
Elena Mezhevitinova
Academician V.I. Kulakov National Medical Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
Email: mejevitinova@mail.ru
PhD, Leading Researcher of the Scientific and Polyclinic Department
Andrey Donnikov
Academician V.I. Kulakov National Medical Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of RussiaPhD, Head of the Laboratory of Molecular Genetic Methods
Patimat Abakarova
Academician V.I. Kulakov National Medical Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
Email: abakarova2002@mail.ru
PhD, Researcher at the Scientific and Polyclinic Department
Elmira Dovletkhanova
Academician V.I. Kulakov National Medical Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
Email: eldoc@mail.ru
PhD, Researcher at the Scientific and Polyclinic Department
Kirill Gusakov
Academician V.I. Kulakov National Medical Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
Email: kigusakov@gmail.com
PhD, Researcher at the Scientific and Polyclinic Department
Angelina Odyvanova
Academician V.I. Kulakov National Medical Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russiapost-graduate student of the Department of Obstetrics, Gynecology, Perinatology and Reproductology
Әдебиет тізімі
- Integrative HMP (iHMP) Research Network Consortium. The integrative human microbiome project. Nature. 2019; 569(7758): 641-8. https://dx.doi.org/10.1038/s41586-019-1238-8.
- Dominguez-Bello M.G., Costello E.K., Contreras M., Magris M., Hidalgo G., Fierer N., Knight R. Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc. Natl. Acad. Sci. USA. 2010; 107(26): 11971-5. https://dx.doi.org/10.1073/pnas.1002601107.
- Koenig J.E., Spor A., Scalfone N., Fricker A.D., Stombaugh J., Knight R. et al. Succession of microbial consortia in the developing infant gut microbiome. Proc. Natl. Acad. Sci. USA. 2010; 108(Suppl. 1): 4578-85. https://dx.doi.org/10.1073/pnas.1000081107.
- Yatsunenko T., Rey F.E., Manary M.J., Trehan I., Dominguez-Bello M.G. et al. Human gut microbiome viewed across age and geography. Nature. 2012; 486(7402): 222-7. https://dx.doi.ois/10.1038/nature11053.
- Gajer P., Brotman R.M., Bai G., Sakamoto J., Schutte U.M.E., Zhong X. et al. Temporal dynamics of the human vaginal microbiota. Sci. Transl. Med. 2012; 4(132): 132ra52. https://dx.doi.org/10.1126/scitranslmed.3003605.
- Faith J.J., Guruge J.L., Charbonneau M., Subramanian S., Seedorf H., Goodman A.L. et al. The long-term stability of the human gut microbiota. Science. 2013; 341(6141): 1237439. https://dx.doi.org/10.1126/science.1237439.
- Haahr T., Jensen J.S., Thomsen L., Duus L., Rygaard K., Humaidan P. Abnormal vaginal microbiota may be associated with poor reproductive outcomes: a prospective study in IVF patients. Hum. Reprod. 2016; 31(4): 795-803. https://dx.doi.org/10.1093/humrep/dew026.
- Brown R.G., Marchesi J.R., Lee Y.S., Smith A., Lehne B. et al. Vaginal dysbiosis increases risk of preterm fetal membrane rupture, neonatal sepsis and is exacerbated by erythromycin. BMC Med. 2018; 16(1): 9. https://dx.doi.org/10.1186/s12916-017-0999-x.
- Менухова Ю.Н. Бактериальный вагиноз: этиопатогенез, клинико-лабораторные особенности. Журнал акушерства и женских болезней. 2013; 62(4): 79-87.
- Филимонова Т.М., Елисютина О.Г., Ниязов Д.Д., Болдырева М.Н., Бурменская О.В., Реброва О.Ю. Локальный и системный иммунный ответ у больных тяжелым атопическим дерматитом. Российский аллергологический журнал. 2011; 5: 10-5.
- Долгушина В.Ф., Смольникова Л.А., Долгушин И.И. Состояние факторов местной иммунной защиты репродуктивного тракта при вагинозе у беременных. Журнал микробиологии, эпидемиологии и иммунобиологии. 2001; 4: 89-93.
- Kali a N., Singh J., Kaur M. Immunopathology of recurrent vulvovaginal infections: new aspects and research directions. Front. Immunol. 2019; 10: 2034. https://dx.doi.org/10.3389/fimmu.2019.02034.
- Centers for Disease Control and Prevention. STD Treatment Guidelines. 2021.
- Reid G. Has knowledge of the vaginal microbiome altered approaches to health and disease? F1000Res. 2018; 7: 460. https://dx.doi.org/10.12688/f1000research.13706.1.
- Sherrard J., Wilson J., Donders G., Mendling W., Jensen J.S. 2018 European (IUSTI/WHO) International Union against sexually transmitted infections (IUSTI) World Health Organisation (WHO) guideline on the management of vaginal discharge. Int. J. STD AIDS. 2018; 29(13): 1258-72. https://dx.doi.org/10.1177/0956462418785451.
- Радзинский В.Е., Ордиянц И.М., Четвертакова Э.С., Мисуно О.А. Двухэтапная терапия вагинальных инфекций. Акушерство и гинекология. 2011; 5: 78-81.
- Прилепская В.Н., Кира Е.Ф., Гомберг М.А., Аполихина И.А., Байрамова Г.Р. Федеральные клинические рекомендации. Диагностика и лечение заболеваний, сопровождающихся патологическими выделениями из половых путей женщин. М.; 2019. 50с.
- Bradshaw C.S., Sobel J.D. Current treatment of bacterial vaginosis-limitations and need for innovation. J. Infect. Dis. 2016; 214(Suppl. 1): S14-20. https://dx.doi.org/10.1093/infdis/jiw159.
- Wilson J. Managing recurrent bacterial vaginosis. Sex. Transm. Infect. 2004; 80(1): 8-11. https://dx.doi.org/10.1136/sti.2002.002733.
- Muzny C.A., Kardas P. A narrative review of current challenges in the diagnosis and management of bacterial vaginosis. Sex. Transm. Dis. 2020; 47(7): 441-6. https://dx.doi.org/10.1097/OLQ.0000000000001178.
- Coudray M.S., Madhivanan P. Bacterial vaginosis - a brief synopsis of the literature. Eur. J. Obstet. Gynecol. Reprod. Biol. 2020; 245: 143-8. https://dx.doi.org/10.1016/j.ejogrb.2019.12.035.
- Marcone V., Calzolari E., Bertini M. Effectiveness of vaginal administration of Lactobacillus rhamnosus following conventional metronidazole therapy: how to lower the rate of bacterial vaginosis recurrences. New Microbiol. 2008; 31(3): 429-33.
- Lopez-Moreno A., Aguilera M. Vaginal probiotics for reproductive health and related dysbiosis: Systematic review and meta-analis. J. Clin. Med. 2021; 10(7): 1461. https:dx.doi.org/10.3390/jcm10071461.
- Hay P. Bacterial vaginosis. F1000Res. 2017; 6: 1761. https://dx.doi.org/10.12688/f1000research.11417.1.
- Senok A.C., Verstraelen H., Temmerman M., Botta G.A. Probiotics for the treatment of bacterial vaginosis. Cochrane Database Syst. Rev. 2009; 4: CD006289. https://dx.doi.org/10.1002/14651858.CD006289.pub2.
- Hanson J.M., McGregor J.A., Hillier S.L., Eschenbach D.A., Kreutner A.K., Galask R.P., Martens M. Metronidazole for bacterial vaginosis. A comparison of vaginal gel vs. oral therapy. J. Reprod. Med. 2000; 45(11): 889-96.
Қосымша файлдар
![](/img/style/loading.gif)